Phase II Pilot Study of Bevacizumab in Combination with Temozolomide and Regional Radiation Therapy for Up-Front Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Interim Analysis of Safety and Tolerability
- 1 August 2008
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 71 (5), 1372-1380
- https://doi.org/10.1016/j.ijrobp.2007.11.068
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Relationship between Survival and Edema in Malignant Gliomas: Role of Vascular Endothelial Growth Factor and Neuronal Pentraxin 2Clinical Cancer Research, 2007
- VEGF Trap in Combination With Radiotherapy Improves Tumor Control in U87 GlioblastomaInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Design of Clinical Trials of Radiation Combined with Antiangiogenic TherapyThe Oncologist, 2007
- Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant GliomaClinical Cancer Research, 2007
- Current status of angiogenesis inhibitors combined with radiation therapyCancer Treatment Reviews, 2006
- MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapyNeurology, 2006
- Radiation-Enhanced Vascular Endothelial Growth Factor (VEGF) Secretion in Glioblastoma Multiforme Cell Lines – A Clue to Radioresistance?Journal of Neuro-Oncology, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Autocrine Pathways of the Vascular Endothelial Growth Factor (VEGF) in Glioblastoma Multiforme: Clinical Relevance of Radiation-Induced Increase of VEGF LevelsJournal of Neuro-Oncology, 2004
- Epidemiology of primary brain tumors: Current concepts and review of the literatureNeuro-Oncology, 2002